Maintenance therapy in autoimmune pancreatitis: a weak light into the darkness

Published on Jun 8, 2017in Annals of Translational Medicine3.297
· DOI :10.21037/ATM.2017.07.06
Luca Frulloni58
Estimated H-index: 58
Nicolò de Pretis8
Estimated H-index: 8
Antonio Amodio13
Estimated H-index: 13
Autoimmune pancreatitis (AIP) is a fibro-inflammatory disease of the pancreas with a postulated immune-mediated mechanism (1,2). Two different histologic subtypes have been described, type 1 and type 2 AIP (3). Type 1 AIP is a more aggressive disease in terms of recurrences and extra-pancreatic organ involvement. International consensus diagnostic criteria (ICDC) have been established to classify the disease without definitive histology (4). ICDC introduced not otherwise specified (NOS) AIP as a third subtype, if type 1 or type 2 AIP cannot be diagnosed.
📖 Papers frequently viewed together
5 Citations
23 Citations
4 Authors (Tetsuhide Ito, ..., Hisato Igarashi)
#1Atsushi Masamune (Tohoku University)H-Index: 67
#2Isao NishimoriH-Index: 55
Last. Tooru Shimosegawa (Tohoku University)H-Index: 95
view all 29 authors...
Objective Corticosteroid has been established as the standard therapy for autoimmune pancreatitis (AIP), but the requirement for maintenance corticosteroid therapy is controversial. We conducted a randomised controlled trial to clarify the efficacy of maintenance corticosteroid therapy in patients with AIP. Design We conducted a multicentre, tertiary setting, randomised controlled trial. After the induction of remission with the initial oral prednisolone (PSL) treatment, maintenance therapy with...
77 CitationsSource
#1Kazuichi Okazaki (Kansai Medical University)H-Index: 85
#2Suresh T. Chari (Mayo Clinic)H-Index: 103
Last. Tooru Shimosegawa (Tohoku University)H-Index: 95
view all 11 authors...
Abstract Background and aims The International Consensus Diagnostic Criteria (ICDC) for AIP has proposed two distinctive type of AIP, type 1 and type 2, and enabled us first to differentiate two types of AIP each other. By initial steroid treatment for induction of remission, remission can be successfully induced in almost all subjects with type 1 and type 2 AIP. As relapse rate in type 1 AIP is significantly higher than in type 2 AIP, there has been ongoing debate on how to treat effectively re...
71 CitationsSource
#1Matthew T. Huggett (UCL: University College London)H-Index: 6
#2Emma L. Culver (John Radcliffe Hospital)H-Index: 17
Last. Eleanor BarnesH-Index: 57
view all 11 authors...
Type 1 Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis Is Associated With Extrapancreatic Organ Failure, Malignancy, and Mortality in a Prospective UK Cohort
131 CitationsSource
#1Tsukasa IkeuraH-Index: 19
#2Sönke Detlefsen (University of Southern Denmark)H-Index: 21
Last. Luca FrulloniH-Index: 58
view all 13 authors...
The objective of this study was to compare the preoperative diagnosis by International Consensus Diagnostic Criteria (ICDC) with histological diagnosis in patients with focal autoimmune pancreatitis (AIP) who underwent surgery.Thirty patients (type 1 AIP in 23 and type 2 AIP in 7) with a diagnosis of AIP based on histology of surgical specimens were classified according to ICDC based on their preoperative data.Pancreatic core biopsies and diagnostic steroid trial were not preoperatively performe...
13 CitationsSource
#1Jorie Buijs (Erasmus University Medical Center)H-Index: 6
Last. Henk R. van BuurenH-Index: 36
view all 13 authors...
textabstractOBJECTIVE: The objective of this study was to compare efficacy of high versus low doses of prednisone for induction of remission in autoimmune pancreatitis (AIP). METHODS: This is a retrospective, multicenter study including patients diagnosed with AIP between May 1992 and August 2011. Clinical, laboratory and imaging findings were assessed before treatment and at 1, 3, and 6 months after starting treatment. RESULTS: A total of 65 patients (57 males; median age, 63 years) were treate...
25 CitationsSource
#1Phil A. Hart (Mayo Clinic)H-Index: 29
#2Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 25 authors...
Objective Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae. Design 23 institutions from 10 different countries participated in this multination...
317 CitationsSource
#1Phil A. Hart (Mayo Clinic)H-Index: 29
#2Mark Topazian (Mayo Clinic)H-Index: 65
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 14 authors...
Background There is a paucity of data on long-term management of type 1 autoimmune pancreatitis (AIP), a relapsing steroid-responsive disorder. Objective We describe our experience with treatment of relapses and maintenance of remission using steroid-sparing immunomodulators (IMs) and induction of remission using rituximab (RTX). Methods We obtained details of disease relapse and treatment in 116 type 1 AIP patients from clinic visits, medical records and telephone interviews. We compared relaps...
235 CitationsSource
#1Masahiro Shiokawa (Kyoto University)H-Index: 13
#2Yuzo Kodama (Kyoto University)H-Index: 35
Last. Tsutomu ChibaH-Index: 105
view all 26 authors...
RESULTS: Of the 108 AIP patients, 18 cancers were found in 15 patients (13.9 % ) during the median follow-up period of 3.3 years. The SIR of cancer was 2.7 (95 % confi dence interval (CI) 1.4 - 3.9), which was stratifi ed into the fi rst year (6.1 (95 % CI 2.3 - 9.9)) and subsequent years (1.5 (95 % CI 0.3 - 2.8)) after AIP diagnosis. Relative risk of cancer among AIP patients at the time of AIP diagnosis was 4.9 (95 % CI 1.7 - 14.9). In six of eight patients whose cancer lesions could be assess...
139 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
#2Suresh T. ChariH-Index: 103
Last. Vay Liang W. Go (UCLA: University of California, Los Angeles)H-Index: 93
view all 22 authors...
: The objective of this study was to clarify the clinical and pathophysiological characteristics of autoimmune pancreatitis (AIP) and its subtypes (lymphoplasmacytic sclerosing pancreatitis [LPSP] and idiopathic duct-centric pancreatitis [IDCP]) seen around the world.: An international multicenter survey of AIP was conducted in 15 institutes from 8 countries. We compared clinical and pathologic profiles of AIP (n = 731) and the clinical profiles of LPSP (n = 204) and IDCP (n = 64) patients.: Pat...
176 CitationsSource
#1Tooru Shimosegawa (Tohoku University)H-Index: 95
#2Suresh T. ChariH-Index: 103
Last. Lizhi ZhangH-Index: 54
view all 14 authors...
Objectives:To achieve the goal of developing international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP).Methods:An international panel of experts met during the 14th Congress of the International Association of Pancreatology held in Fukuoka, Japan, from July 11 through 13,
896 CitationsSource
Cited By5
#1Sushil Kumar GargH-Index: 23
#2Suresh T. ChariH-Index: 103
#1Seung Bae Yoon (Catholic University of Korea)H-Index: 10
#2Sung-Hoon Moon (Hallym University)H-Index: 8
Last. Myung-Hwan Kim (UOU: University of Ulsan)H-Index: 89
view all 0 authors...
Abstract null null Background null The indications for maintenance glucocorticoid therapy (MGT) and its duration after initial remission of type 1 autoimmune pancreatitis (AIP) remain controversial. In contrast to the Japanese treatment protocol, the Mayo protocol does not recommend MGT after initial remission. This study aimed to evaluate the relapse rate in patients with type 1 AIP according to the duration of glucocorticoid therapy. null null null Methods null We conducted a systematic litera...
1 CitationsSource
#1Matteo Tacelli (University of Palermo)H-Index: 5
#2Ciro Celsa (University of Palermo)H-Index: 10
Last. Calogero Cammà (University of Palermo)H-Index: 76
view all 9 authors...
Background & Aims Risk for relapse after induction of remission with steroid therapy has been studied extensively in patients with autoimmune pancreatitis (AIP), but findings have been equivocal. We performed a systematic review and meta-analysis to estimate the relapse rate of AIP after initial remission after steroid treatment and to identify factors associated with relapse. Methods Three reviewers searched MEDLINE, SCOPUS, and EMBASE until July 2018 to identify studies on rate of relapse of A...
9 CitationsSource
: Type 1 autoimmune pancreatitis (AIP) is an IgG-4-related systemic disease that can manifest as a pancreatic disorder or another disorder of presumed autoimmune origin. Type 2 disease is typically characterized by absent IgG-4-positive cells. As patients often present with acute pancreatitis, obstructive jaundice, or pancreatic mass, it is imperative to exclude malignancy, a more common diagnosis. AIP may respond to corticosteroids, and has a strong association with other immune-mediated diseas...
8 CitationsSource
#1Nicolò de Pretis (University of Verona)H-Index: 8
#2Giulia De MarchiH-Index: 6
Last. Luca FrulloniH-Index: 58
view all 3 authors...
Purpose of review Clinical management of autoimmune pancreatitis changed over the last years. The lack of high-quality studies, probably due to the relative rarity of the disease, has not fully clarified many diagnostic and therapeutic aspects. Aim of this review is to overview the literature from a clinical point of view, focusing on diagnostic and therapeutic approach to this complicated disease. Recent findings They have been focused mainly on the risk of misdiagnosing a cancer. Many signific...
1 CitationsSource
#1Nicolò de Pretis (University of Verona)H-Index: 8
#2Antonio Amodio (University of Verona)H-Index: 13
Last. Luca Frulloni (University of Verona)H-Index: 58
view all 3 authors...
ABSTRACTIntroduction: Autoimmune Pancreatitis (AIP) is a peculiar form of pancreatitis different from all other type of pancreatitis (‘one like no one pancreatitis’) and characterized by a dramatic response to steroids. AIP can be classified histologically in type 1, included in a larger group of diseases named IgG4-related disease, and type 2. At imaging, AIP may involve all (diffuse form) or only a part (focal form) of the pancreatic gland.Areas covered: In this article, the clinical approach ...
5 CitationsSource